Similarly, due to the vast difference of IPF proteome and HSPome compared to controls, inhibition of HSP90 is a promising intervention which could impede the profound changes in protein expression observed in late stage of the disease. This evidence concerns the gene HSP90AA1 and idiopathic pulmonary fibrosis.